vs

Side-by-side financial comparison of Capri Holdings Ltd (CPRI) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× Capri Holdings Ltd). Dexcom runs the higher net margin — 21.2% vs 11.3%, a 9.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -18.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -15.2%).

Capri Holdings Limited is a multinational fashion holding company, incorporated in the British Virgin Islands, with executive offices in London and operational offices in New York. It was founded in 1981 by American designer Michael Kors. The company sells clothes, shoes, watches, handbags, and other accessories. In 2015, the company had more than 550 stores and over 1,500 in-store boutiques in various countries.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

CPRI vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.2× larger
DXCM
$1.3B
$1.0B
CPRI
Growing faster (revenue YoY)
DXCM
DXCM
+40.3% gap
DXCM
21.6%
-18.7%
CPRI
Higher net margin
DXCM
DXCM
9.9% more per $
DXCM
21.2%
11.3%
CPRI
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-15.2%
CPRI

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CPRI
CPRI
DXCM
DXCM
Revenue
$1.0B
$1.3B
Net Profit
$116.0M
$267.3M
Gross Margin
60.8%
62.9%
Operating Margin
4.5%
25.6%
Net Margin
11.3%
21.2%
Revenue YoY
-18.7%
21.6%
Net Profit YoY
121.2%
153.6%
EPS (diluted)
$0.96
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPRI
CPRI
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$1.0B
$1.3B
Q3 25
$856.0M
$1.2B
Q2 25
$797.0M
$1.2B
Q1 25
$1.6B
$1.0B
Q4 24
$1.1B
$1.1B
Q3 24
$878.0M
$994.2M
Q2 24
$848.0M
$1.0B
Net Profit
CPRI
CPRI
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$116.0M
$267.3M
Q3 25
$-28.0M
$283.8M
Q2 25
$53.0M
$179.8M
Q1 25
$-645.0M
$105.4M
Q4 24
$-547.0M
$151.7M
Q3 24
$24.0M
$134.6M
Q2 24
$-14.0M
$143.5M
Gross Margin
CPRI
CPRI
DXCM
DXCM
Q1 26
62.9%
Q4 25
60.8%
62.9%
Q3 25
61.0%
60.5%
Q2 25
63.0%
59.5%
Q1 25
64.9%
56.9%
Q4 24
63.1%
58.9%
Q3 24
62.3%
59.7%
Q2 24
63.1%
62.4%
Operating Margin
CPRI
CPRI
DXCM
DXCM
Q1 26
25.6%
Q4 25
4.5%
25.6%
Q3 25
-1.4%
20.1%
Q2 25
2.0%
18.4%
Q1 25
-47.5%
12.9%
Q4 24
2.4%
17.0%
Q3 24
-0.7%
15.3%
Q2 24
1.3%
15.7%
Net Margin
CPRI
CPRI
DXCM
DXCM
Q1 26
21.2%
Q4 25
11.3%
21.2%
Q3 25
-3.3%
23.5%
Q2 25
6.6%
15.5%
Q1 25
-39.1%
10.2%
Q4 24
-51.2%
13.6%
Q3 24
2.7%
13.5%
Q2 24
-1.7%
14.3%
EPS (diluted)
CPRI
CPRI
DXCM
DXCM
Q1 26
$0.67
Q4 25
$0.96
$0.67
Q3 25
$-0.22
$0.70
Q2 25
$0.44
$0.45
Q1 25
$-5.47
$0.27
Q4 24
$-4.61
$0.37
Q3 24
$0.20
$0.34
Q2 24
$-0.12
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPRI
CPRI
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$154.0M
$917.7M
Total DebtLower is stronger
$234.0M
Stockholders' EquityBook value
$105.0M
$2.7B
Total Assets
$3.3B
$6.3B
Debt / EquityLower = less leverage
2.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPRI
CPRI
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$154.0M
$917.7M
Q3 25
$120.0M
$1.8B
Q2 25
$129.0M
$1.2B
Q1 25
$107.0M
$904.9M
Q4 24
$356.0M
$606.1M
Q3 24
$182.0M
$621.2M
Q2 24
$213.0M
$939.2M
Total Debt
CPRI
CPRI
DXCM
DXCM
Q1 26
Q4 25
$234.0M
Q3 25
$1.8B
Q2 25
$1.7B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.7B
Q2 24
$1.7B
Stockholders' Equity
CPRI
CPRI
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$105.0M
$2.7B
Q3 25
$-74.0M
$2.7B
Q2 25
$-17.0M
$2.6B
Q1 25
$368.0M
$2.3B
Q4 24
$1.1B
$2.1B
Q3 24
$1.5B
$2.0B
Q2 24
$1.6B
$2.4B
Total Assets
CPRI
CPRI
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$3.3B
$6.3B
Q3 25
$5.6B
$7.5B
Q2 25
$5.5B
$7.3B
Q1 25
$5.2B
$6.8B
Q4 24
$5.9B
$6.5B
Q3 24
$6.8B
$6.4B
Q2 24
$6.6B
$6.8B
Debt / Equity
CPRI
CPRI
DXCM
DXCM
Q1 26
Q4 25
2.23×
Q3 25
Q2 25
Q1 25
4.05×
Q4 24
1.38×
Q3 24
1.15×
Q2 24
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPRI
CPRI
DXCM
DXCM
Operating Cash FlowLast quarter
$202.0M
Free Cash FlowOCF − Capex
$183.0M
FCF MarginFCF / Revenue
17.9%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
1.74×
TTM Free Cash FlowTrailing 4 quarters
$-134.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPRI
CPRI
DXCM
DXCM
Q1 26
Q4 25
$202.0M
$294.0M
Q3 25
$-52.0M
$659.9M
Q2 25
$-8.0M
$303.0M
Q1 25
$-161.0M
$183.8M
Q4 24
$309.0M
$301.4M
Q3 24
$50.0M
$199.5M
Q2 24
$83.0M
$279.4M
Free Cash Flow
CPRI
CPRI
DXCM
DXCM
Q1 26
Q4 25
$183.0M
$192.1M
Q3 25
$-65.0M
$579.4M
Q2 25
$-21.0M
$208.9M
Q1 25
$-231.0M
$96.8M
Q4 24
$287.0M
$176.8M
Q3 24
$30.0M
$88.3M
Q2 24
$67.0M
$213.3M
FCF Margin
CPRI
CPRI
DXCM
DXCM
Q1 26
Q4 25
17.9%
15.3%
Q3 25
-7.6%
47.9%
Q2 25
-2.6%
18.1%
Q1 25
-14.0%
9.3%
Q4 24
26.9%
15.9%
Q3 24
3.4%
8.9%
Q2 24
7.9%
21.2%
Capex Intensity
CPRI
CPRI
DXCM
DXCM
Q1 26
Q4 25
1.9%
8.1%
Q3 25
1.5%
6.7%
Q2 25
1.6%
8.1%
Q1 25
4.2%
8.4%
Q4 24
2.1%
11.2%
Q3 24
2.3%
11.2%
Q2 24
1.9%
6.6%
Cash Conversion
CPRI
CPRI
DXCM
DXCM
Q1 26
Q4 25
1.74×
1.10×
Q3 25
2.33×
Q2 25
-0.15×
1.69×
Q1 25
1.74×
Q4 24
1.99×
Q3 24
2.08×
1.48×
Q2 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPRI
CPRI

Michael Kors Segment$593.0M58%
Other$379.0M37%
Jimmy Choo Segment$53.0M5%

DXCM
DXCM

Segment breakdown not available.

Related Comparisons